Earnings
BerGenBio ASA will announce its results for the third quarter 2018 on Tuesday, 13 November 2018.
Acacia Pharma Group plc announces its unaudited results for the nine months to 30 September 2018 to provide an update on current trading and its cash position.
Advancing proprietary pipeline; solid progress in partnered programs
Ultragenyx Pharmaceutical Inc. today reported its financial results and corporate update for the quarter ended September 30, 2018.
Recipharm will publish its interim report for January-September 2018 on the 8th November at 07:45 am CET.
Neos Therapeutics, Inc. today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial markets on Friday, November 9, 2018.
ZEJULA® Q3 net sales totaled $63 million compared to $39 million for Q3 2017
Esperion today provided bempedoic acid franchise development program updates and financial results for the third quarter ended September 30, 2018.
Pivotal programs enrolling towards first data readout in 2019
Catalyst Pharmaceuticals, Inc. today announced that it will release third quarter 2018 financial results after market close on Wednesday, November 7, 2018.
PRESS RELEASES